VOGT: when the article was written, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX; currently, Psychological and Brain Sciences, Texas A&M University, College Station, TX

AVENDAÑO-ORTEGA, SCHNEIDER, GOODMAN, and STORCH: Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX

Supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) under award number 1UH3NS100549-01, the National Institute of Mental Health under award number 1RF1MH121371, and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number P50HD103555 for use of the Clinical and Translational Core facilities. Opinions expressed in this article are those of the authors and do not necessarily reflect those of NIH.

W.K.G. received an honorarium from Biohaven Pharmaceuticals. He receives research grant support from NIH, the McNair Foundation, and Biohaven Pharmaceuticals. He receives donated medical devices from Medtronic. E.A.S. receives book royalties from Elsevier, Jessica Kingsley, American Psychological Association, Springer, Lawrence Erlbaum, and Wiley. He is a consultant for Biohaven and Brainsway. He holds stock in NView. He receives grant support from NIH, Ream Foundation, Texas Higher Education Coordinating Board, Greater Houston Community Foundation. The remaining authors declare no conflicts of interest.

Please send correspondence to: Gregory S. Vogt, 230 Psychology Bldg, 4235 TAMU, College Station, TX 77843 (e-mail: [email protected]).